← Open Payments lookup

MICHAEL KILLIAN: Open Payments

NPI 1851342026 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,409 in 123 payments from 23 companies in 2025. Trend: 2023 $2,201 · 2024 $1,874 · 2025 $2,409

Food & beverage: $2,399Education: $10
CompanyPaymentsAmount
Gilead Sciences, Inc.25$597
Novo Nordisk Inc15$303
AstraZeneca Pharmaceuticals LP14$241
ViiV Healthcare Company7$185
Takeda Pharmaceuticals U.S.A., Inc.12$148
Phathom Pharmaceuticals, Inc.8$114
Merck Sharp & Dohme LLC5$106
Lilly USA, LLC5$95
PFIZER INC.5$92
TOLMAR, INC.4$74

Products named: TRINTELLIX, AIRSUPRA, VOQUEZNA, Biktarvy, MOUNJARO, Wegovy, APRETUDE, JATENZO.

Industry payments across TX — which companies pay providers there.